Immunome, Inc. (IMNM)
NASDAQ: IMNM · Real-Time Price · USD
10.21
+0.04 (0.39%)
At close: Jan 22, 2025, 4:00 PM
10.37
+0.16 (1.57%)
After-hours: Jan 22, 2025, 4:32 PM EST
Immunome Market Cap
Immunome has a market cap or net worth of $637.28 million as of January 22, 2025. Its market cap has increased by 34.12% in one year.
Market Cap
637.28M
Enterprise Value
399.87M
1-Year Change
34.12%
Ranking
Category
Stock Price
$10.21
Market Cap Chart
Since the IPO on October 2, 2020, Immunome's market cap has increased from $111.39M to $637.28M, an increase of 472.11%. That is a compound annual growth rate of 49.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2025 | 637.28M | -3.86% |
| Dec 31, 2024 | 662.87M | 44.98% |
| Dec 29, 2023 | 457.21M | 1,605.70% |
| Dec 30, 2022 | 26.80M | -82.91% |
| Dec 31, 2021 | 156.82M | 53.68% |
| Dec 31, 2020 | 102.04M | -8.39% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.64B |
| UnitedHealth Group | 477.92B |
| Novo Nordisk | 360.47B |
| Johnson & Johnson | 349.71B |
| AbbVie | 298.91B |
| Merck & Co. | 242.01B |
| Thermo Fisher Scientific | 219.73B |
| Intuitive Surgical | 217.43B |